SysMedSUDs

Meinhardt, M. W., F. Giannone, N. Hirth, D. Bartsch, S. M. Spampinato, W. Kelsch, R. Spanagel, W. H. Sommer and A. C. Hansson (2022). "Disrupted circadian expression of beta-arrestin 2 affects reward-related micro-opioid receptor function in alcohol dependence." J Neurochem 160(4): 454-468. SysMedSUD www.ncbi.nlm.nih.gov/pubmed/34919270.

Zillich, L., J. Frank, F. Streit, M. M. Friske, J. C. Foo, L. Sirignano, S. Heilmann-Heimbach, H. Dukal, F. Degenhardt, P. Hoffmann, A. C. Hansson, M. M. Nöthen, M. Rietschel, R. Spanagel and S. H. Witt (2022). "Epigenome-wide association study of alcohol use disorder in five brain regions." Neuropsychopharmacology 47(4): 832. SysMedSUDs, Target-OXY doi.org/10.1038/s41386-021-01228-7.

Biernacka, J. M., B. J. Coombes, A. Batzler, A. M.-C. Ho, J. R. Geske, J. Frank, C. Hodgkinson, M. Skime, C. Colby, L. Zillich, S. Pozsonyiova, M.-F. Ho, F. Kiefer, M. Rietschel, R. Weinshilboum, S. S. O’Malley, K. Mann, R. Anton, D. Goldman and V. M. Karpyak (2021). "Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study." Neuropsychopharmacol 46: 2132–2139. SysMedSUDs doi.org/10.1038/s41386-021-01097-0.

Hansson, A. C. and R. Spanagel (2021). "No changes in the oxytocin system in alcohol-dependent female rodents and humans: Towards a sex-specific psychopharmacology in alcoholism." Addict Biol 26(2). Target-OXY & SysMedSUDs doi.org/10.1111/adb.12945.

Hasanpour, M., E. Mitricheva, N. Logothetis and H. R. Noori (2021). "Intensive longitudinal characterization of multidimensional biobehavioral dynamics in laboratory rats." Cell Reports 35(2): 108987. NeuroCon & SysMedSUDs doi.org/10.1016/j.celrep.2021.108987.

Li, W., J. H. Thygesen, N. L. O’Brien, M. Heydtmann, I. Smith, F. Degenhardt, M. M. Nöthen, M. Y. Morgan, N. J. Bass and A. McQuillin (2021). "The influence of regression models on genome-wide association studies of alcohol dependence: a comparison of binary and quantitative analyses." Psychiatric Genetics 31(1): 13-20. SysMedAlcoholism & SysMedSUDs journals.lww.com/psychgenetics/Fulltext/2021/02000/The_influence_of_regression_models_on_genome_wide.2.aspx.

Meinhardt, M. W., S. Pfarr, G. Fouquet, C. Rohleder, M. L. Meinhardt, J. Barroso-Flores, R. Hoffmann, J. Jeanblanc, E. Paul, K. Wagner, A. C. Hansson, G. Köhr, N. Meier, O. von Bohlen und Halbach, R. L. Bell, H. Endepols, B. Neumaier, K. Schönig, D. Bartsch, M. Naassila, R. Spanagel and W. H. Sommer (2021). "Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism." Sci Adv. SysMedSUDs www.science.org/doi/10.1126/sciadv.abh2399.

Russo, E., T. Ma, R. Spanagel, D. Durstewitz, H. Toutounji and G. Köhr (2021). "Coordinated Prefrontal State Transition Leads Extinction of Reward-Seeking Behaviors." J. Neurosci. 41(11): 2406–2419. SysMedAlcoholism, SysMedSUDs doi.org/10.1523/JNEUROSCI.2588-20.2021.

Scherrer, B., J. Guiraud, G. Addolorato, H. J. Aubin, A. de Bejczy, A. Benyamina, W. van den Brink, F. Caputo, M. Dematteis, A. E. Goudriaan, A. Gual, F. Kiefer, L. Leggio, O. M. Lesch, I. Maremmani, D. J. Nutt, F. Paille, P. Perney, R. Poulnais, Q. Raffaillac, J. Rehm, B. Rolland, N. Simon, B. Soderpalm, W. H. Sommer, H. Walter and R. Spanagel (2021). "Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta-regression analysis to develop an enrichment strategy." Alcohol Clin Exp Res 45(9): 1722-1734. SysMedSUDs www.ncbi.nlm.nih.gov/pubmed/34418121.

Schuster, R., M. Winkler, A. Koopmann, P. Bach, S. Hoffmann, I. Reinhard, R. Spanagel, J. M. Bumb, W. H. Sommer and F. Kiefer (2021). "Calcium Carbonate Attenuates Withdrawal and Reduces Craving: A Randomized Controlled Trial in Alcohol-Dependent Patients." Eur. Addict. Res.: 1–9. SysMEDSUDs doi.org/10.1159/000512763.

Smigielski, L., S. Papiol, A. Theodoridou, K. Heekeren, M. Gerstenberg, D. Wotruba, R. Buechler, P. Hoffmann, S. Herms, K. Adorjan, H. Anderson-Schmidt, M. Budde, A. L. Comes, K. Gade, M. Heilbronner, U. Heilbronner, J. L. Kalman, F. Klöhn-Saghatolislam, D. Reich-Erkelenz, S. K. Schaupp, E. C. Schulte, F. Senner, I.-G. Anghelescu, V. Arolt, B. T. Baune, U. Dannlowski, D. E. Dietrich, A. J. Fallgatter, C. Figge, M. Jäger, G. Juckel, C. Konrad, V. Nieratschker, J. Reimer, E. Reininghaus, M. Schmauß, C. Spitzer, M. von Hagen, J. Wiltfang, J. Zimmermann, A. Gryaznova, L. Flatau-Nagel, M. Reitt, M. Meyers, B. Emons, I. S. Haußleiter, F. U. Lang, T. Becker, M. E. Wigand, S. H. Witt, F. Degenhardt, A. J. Forstner, M. Rietschel, M. M. Nöthen, T. F. M. Andlauer, W. Rössler, S. Walitza, P. Falkai, T. G. Schulze and E. Grünblatt (2021). "Polygenic risk scores across the extended psychosis spectrum." Transl Psychiatry 11(600): 1–11. IntegraMent & SysMedSUDs & Target-OXY doi.org/10.1038/s41398-021-01720-0.

Spanagel, R. and A. Bilbao (2021). "Approved cannabinoids for medical purposes – Comparative systematic review and meta-analysis for sleep and appetite." Neuropharmacology 196: 108680. SysMedSUDs doi.org/10.1016/j.neuropharm.2021.108680.

Surakka, A., V. Vengeliene, I. Skorodumov, M. Meinhardt, A. C. Hansson and R. Spanagel (2021). "Adverse social experiences in adolescent rats result in persistent sex-dependent effects on alcohol-seeking behavior." Alcohol Clin Exp Res 45(7): 1468-1478. SysMedSUDs www.ncbi.nlm.nih.gov/pubmed/34273113.

Velo Escarcena, L., M. Neufeld, M. Rietschel, R. Spanagel and H. Scholz (2021). "ERR and dPECR Suggest a Link Between Neuroprotection and the Regulation of Ethanol Consumption Preference." Frontiers in Psychiatry 12. SysMedAlcoholism & SysMedSUDs www.frontiersin.org/article/10.3389/fpsyt.2021.655816.

Wei, S., S. Hertle, R. Spanagel and A. Bilbao (2021). "NMDA Receptors in Accumbal D1 Neurons Influence Chronic Sugar Consumption and Relapse." eNeuro 8(3). SysMedSUDs doi.org/10.1523/ENEURO.0029-21.2021.

Bilbao, A., D. Neuhofer, M. Sepers, S.-p. Wei, M. Eisenhardt, S. Hertle, O. Lassalle, A. Ramos-Uriarte, N. Puente, R. Lerner, A. Thomazeau, P. Grandes, B. Lutz, O. J. Manzoni and R. Spanagel (2020). "Endocannabinoid LTD in Accumbal D1 Neurons Mediates Reward-Seeking Behavior." ISCIENCE 23(3). SysMedAlcoholism & SysMedSUDs doi.org/10.1016/j.isci.2020.100951.

Cannella, N., A. Cosa-Linan, T. Takahashi, W. Weber-Fahr and R. Spanagel (2020). "Cocaine addicted rats show reduced neural activity as revealed by manganese-enhanced MRI." Sci Rep 10(19353): 1–14. SysMedSUDs doi.org/10.1038/s41598-020-76182-3.

De Santis, S., A. Cosa-Linan, R. Garcia-Hernandez, L. Dmytrenko, L. Vargova, I. Vorisek, S. Stopponi, P. Bach, P. Kirsch, F. Kiefer, R. Ciccocioppo, E. Sykova, D. Moratal, W. H. Sommer and S. Canals (2020). "Chronic alcohol consumption alters extracellular space geometry and transmitter diffusion in the brain." Sci Adv 6(26): eaba0154. Target-OXY, SysMedSUDs doi.org/10.1126/sciadv.aba0154.

Domi, E., L. Xu, M. Paetz, A. Nordeman, G. Augier, L. Holm, S. Toivainen, E. Augier, A. C. Hansson and M. Heilig (2020). "Nicotine increases alcohol self-administration in male rats via a mu-opioid mechanism within the mesolimbic pathway." Br J Pharmacol 177(19): 4516-4531. SysMedSUDs doi.org/10.1111/bph.15210.

Egenrieder, L., E. Mitricheva, R. Spanagel and H. R. Noori (2020). "No basal or drug-induced sex differences in striatal dopaminergic levels: a cluster and meta-analysis of rat microdialysis studies." J Neurochem. SysMedSUDs & NeuroCon doi.org/10.1111/jnc.14911.

Meinhardt, M. W., C. Guengoer, I. Skorodumov, L. J. Mertens and R. Spanagel (2020). "Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse." Neuropsychopharmacology 45(8): 1316-1322. SysMedSUDs doi.org/10.1038/s41386-020-0694-z.

Spanagel, R. (2020). "Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions." Dialogues Clin Neurosci 22(3): 241. SysMedSUDs doi.org/10.31887/DCNS.2020.22.3/rspanagel.

Vengeliene, V., J. C. Foo and J. Kim (2020). "Translational approach to understanding momentary factors associated with alcohol consumption." Br J Pharmacol 177(17): 3878–3897. SysMedSUDs & Target-OXY doi.org/10.1111/bph.15180.

Witt, S. H., J. Frank, U. Frischknecht, J. Treutlein, F. Streit, J. C. Foo, L. Sirignano, H. Dukal, F. Degenhardt, A. Koopmann, S. Hoffmann, G. Koller, O. Pogarell, U. W. Preuss, P. Zill, K. Adorjan, T. G. Schulze, M. Nöthen, R. Spanagel, F. Kiefer and M. Rietschel (2020). "Acute alcohol withdrawal and recovery in men lead to profound changes in DNA methylation profiles – a longitudinal clinical study." Addiction 115(11): 2034-2044. SysMedAlcoholism & SysMedSUDs & IntegraMent doi.org/10.1111/add.15020.

Bernardi, R. F., A. Olevska, I. Morella, S. Fasano, E. Santos, R. Brambilla and R. Spanagel (2019). "The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice." Journal of Neuroscience 39(32): 6325-6338. SysMedSUDs www.ncbi.nlm.nih.gov/pubmed/31182637.

Pressemeldung des ZI Mannheim (November 2021)
 

Print/Web

• SZ Magazin - Pilz statt Pils?
• Technology Networks - Magic Mushroom Compound Reduces Excessive Drinking in Rat Study
• Discover Magazin - Probing How Magic Mushrooms Might Help Cure Addiction
• INVERSE - Magic mushroom study suggests psilocybin may reverse alcohol-induced brain damage
• RTL.de - Bis zu 90% werden rückfällig: Dank Zauberpilzen der Alkoholsucht entkommen?
• Apotheke Adhoc - Psilocybin: Pilzhalluzinogen gegen Alkoholsucht?
• Die Rheinpfalz - Alkoholismus: Zauberpilze gegen die Sucht

Radio/Podcast

• Deutschlandfunk Kultur - Mit Magic Mushrooms gegen die Alkoholsucht
• Radio Eins (rbb) - Magic Mushrooms als Mittel gegen Alkoholabhängigkeit?
• BR - Alkoholsucht: Wirkstoff aus Pilzen verringert Rückfälle
• Podcast Provisorisches Legal - Streichzug gegen König Alkohol